MVA newsletter no 2, February 2004
: NEWS INDEX
- MVA Annual BioMeeting - 31 March 2004
- New MVA Publication: Medicon Valley Financing Guide
- Changed rules for ownership of innovations by university researchers in Sweden?
- MVA press release: Future biotech financing - will Medicon Valley remain in the bio-elite of Europe?
- Communication course for ph.d. students
- Jobs in the region: Job openings at Active Biotech and L'Oréal
- New biotech centre at the Technical University of Denmark
- The two Medicon Valley companies - BioInvent in Lund and ALK-Abelló in Hørsholm - enter agreement
- CellaVision awarded the City of Malmö Business Prize in medicine
- LICA Pharmaceuticals and Walter Reed Army Institute of Research, US Army in collaboration
- Denmarks largest research park is a reality
- Summary from the conference "Medical Research Funding – Vision for the 21st Century"
: MVA NEWS
MVA Annual BioMeeting - 31 March 2004
31 March 2004 / Börshuset / Malmö
MVA invites to a half-day conference for scientists and business representatives from universities, hospitals and industry in the Øresund region. See updated program focusing on innovation and business.
More information... (English) www.mva.org/composite-720.htm
New MVA Publication: Medicon Valley Financing Guide
A publication to help biotech and medicotech companies in Medicon Valley to identify and approach potential investors, thereby increasing their chances of attracting national and international venture capital. MVA have focused particularly on international venture capital, the importance of which is becoming clear to an increasing proportion of companies in Medicon Valley.
More information... (English) www.mva.org/composite-69.htm
Changed rules for ownership of innovations by university researchers in Sweden?
Summary of the ongoing debate in Sweden. What is your view on the proposal? Can Sweden learn from the experience in Denmark? Contact Medicon Valley Academy with your point of view.
More information... (English) www.mva.org/composite-924.htm
MVA press release: Future biotech financing - will Medicon Valley remain in the bio-elite of Europe?
The American investor and merchant bank, Burrill & Company, sees Medicon Valley and the Oxford/Cambridge/London region as the absolute elite of European biotech regions. But what will the future bring?
More information... (Danish) www.mva.org/composite-902.htm
Communication course for ph.d. students
In cooperation with MVA, the communication firm Høyer & Mathiasen offers a communication course for ph.d. students on how to communicate science to the public.
More information... (Danish) www.mva.org/composite-916.htm
Jobs in the region: Job openings at Active Biotech and L'Oréal
In the MVA job database, Medicon Valley companies can post job openings and job applicants can post their CV's. Job openings now: Bioanalyst at Active Biotech, and Scientific Officer at L'Oréal.
More information... (English) www.mva.org/composite-672.htm
: MEDICON VALLEY NEWS
New biotech centre at the Technical University of Denmark
The Technical University of Denmark (DTU) recently inaugurated the Centre for Microbial Biotechnology (CMB) - a DKK 36 million investment.
More information... (Danish) www.mva.org/composite-913.htm
The two Medicon Valley companies - BioInvent in Lund and ALK-Abelló in Hørsholm - enter agreement
BioInvent International AB recently announced the signing of a supply agreement with ALK-Abelló A/S for the commercial supply of a new generation of antibodies used in ALK-Abelló’s manufacturing of specific IgE assays for allergy testing on the ADVIA Centaur®, a multi-purpose immunoassay system marketed by Bayer Diagnostics.
More information... (English) www.mva.org/composite-917.htm
CellaVision awarded the City of Malmö Business Prize in Medicine
CellaVision, founded by Christer Fåhreus, has 40 employees. The company strategy is to develop and market automated solutions for microscopy in medicine.
More information... (Swedish) www.mva.org/composite-912.htm
LICA Pharmaceuticals and Walter Reed Army Institute of Research, US Army in collaboration
LICA Pharmaceuticals and the Walter Reed Army Institute of Research, US Army, have signed a cooperative research and development agreement to further develop LICA’s antimalarial drug candidate.
More information... (English) www.mva.org/composite-905.htm
Denmarks largest research park is a reality
The research centre in Hørsholm and the Technical University of Denmark (DTU) unite their research centre activities in a new corporation - SCION•DTU A/S.
More information... (Danish) www.mva.org/composite-904.htm
Summary from the conference "Medical Research Funding – Vision for the 21st Century"
The objective was to discuss how medical research and funding should be organized in the future. The heads of several of the world's leading medical research organizations and councils were participating in the program.
More information... (English) www.mva.org/composite-899.htm
: EVENTS
The legal challenges of the biotech- and medical industries
24-25 February 2004 / Copenhagen / Denmark
An understanding of the immense and important issues of cooperation, patenting and rights have become imperative for any biotech- and medical company today. This conference works with the legal aspects of these industries from lab to market.
More information... (Danish) www.mva.org/composite-852.htm
Riskkapitaldagen 2004
23 March 2003 / Näringslivets Hus / Stockholm / Sweden
MVA members: 20% fee reduction.
The latest on what, where, who, how, and when on risk capital in Sweden and how to attract international capital to Sweden.
More information... (Swedish) www.mva.org/composite-900.htm
Biostatistics course: Statistical computing with R
14-16 April 2004 / Panum Institute / Copenhagen / Denmark
The aim of the course is to give an overview of statistical computing techniques using advanced aspects of the R language and environment for researchers in statistical methods.
More information... (English) www.mva.org/composite-886.htm
The Baltic Summer School 2004
22 August - 3 September 2004 / Lund University / Sweden
3-10 September 2004 / Universities of Lund, Kiel and Copenhagen
Diabetes, molecular heterogeneity, mechanisms and emerging technologies - a course for scientists at the late phase of their ph.d. studies as well as at the medical specialist or post-doc levels.
More information... (English) www.mva.org/composite-914.htm
XVIIIth International Symposium on Medicinal Chemistry
15-19 August 2004 / Copenhagen, Denmark & Malmö, Sweden
The ISMC 2004 will illustrate the integration of the complementary industrial and academic drug design approaches.
More information (English) www.mva.org/composite-918.htm